Company
Headquarters: Shenzhen, China
Employees: 1,002
CEO: Mr. Li Sheng Zhao
HK$354.8 Million
HKD as of July 1, 2024
US$45.4 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products in the People's Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, and internationally. The company also supplies general foodstuffs and medical products. It offers products for various functional categories, such as cough and phlegm relieving, gastrointestinal, vitamin, orthopedics, cardiovascular, influenza, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kawai Product Range, Flying Eagle Wood Lok Medicated Oil, Kyushin Pill, and Mentholatum Product Range brands. The company also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices. In addition, it is involved in the property investment business. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Kingworld Medicines Group Ltd has the following listings and related stock indices.
Stock: HKEX: 1110 wb_incandescent